176 related articles for article (PubMed ID: 22564101)
1. Insulin initiation in type 2 diabetes: what are the treatment regimen options and how can we best help patients feel empowered?
Spollett GR
J Am Acad Nurse Pract; 2012 Apr; 24 Suppl 1():249-59. PubMed ID: 22564101
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic choices, and the nurse practitioner's role, in type 2 diabetes when metformin alone is no longer enough.
Tierney K
J Am Acad Nurse Pract; 2012 Apr; 24 Suppl 1():234-48. PubMed ID: 22564100
[TBL] [Abstract][Full Text] [Related]
3. Partnering with patients to improve therapeutic outcomes: incretin-based therapy for type 2 diabetes.
Nadeau DA
Postgrad Med; 2010 May; 122(3):7-15. PubMed ID: 20463409
[TBL] [Abstract][Full Text] [Related]
4. When oral agents fail: optimizing insulin therapy in the older adult.
Meece J
Consult Pharm; 2009 Jun; 24 Suppl B():11-7. PubMed ID: 19555131
[TBL] [Abstract][Full Text] [Related]
5. Effective switch from premixed to basal-prandial insulin to achieve glycemic goals in type 2 diabetes.
Lavernia F
Postgrad Med; 2010 May; 122(3):28-32. PubMed ID: 20463411
[TBL] [Abstract][Full Text] [Related]
6. In support of an early polypharmacy approach to the treatment of type 2 diabetes.
Wright EE; Stonehouse AH; Cuddihy RM
Diabetes Obes Metab; 2010 Nov; 12(11):929-40. PubMed ID: 20880339
[TBL] [Abstract][Full Text] [Related]
7. Dosing of insulin glargine in the treatment of type 2 diabetes.
Barnett A
Clin Ther; 2007 Jun; 29(6):987-99. PubMed ID: 17692716
[TBL] [Abstract][Full Text] [Related]
8. Insulin treatment for type 2 diabetes: when to start, which to use.
Hamaty M
Cleve Clin J Med; 2011 May; 78(5):332-42. PubMed ID: 21536829
[TBL] [Abstract][Full Text] [Related]
9. DPP-4 inhibitors and GLP-1 analogues: for whom? Which place for incretins in the management of type 2 diabetic patients?
Halimi S
Diabetes Metab; 2008 Feb; 34 Suppl 2():S91-5. PubMed ID: 18640591
[TBL] [Abstract][Full Text] [Related]
10. Why, when and how to initiate insulin therapy in patients with type 2 diabetes.
Tibaldi J; Rakel RE
Int J Clin Pract; 2007 Apr; 61(4):633-44. PubMed ID: 17394436
[TBL] [Abstract][Full Text] [Related]
11. Sitagliptin: a novel drug for the treatment of type 2 diabetes.
Choy M; Lam S
Cardiol Rev; 2007; 15(5):264-71. PubMed ID: 17700385
[TBL] [Abstract][Full Text] [Related]
12. Improving treatment satisfaction and other patient-reported outcomes in people with type 2 diabetes: the role of once-daily insulin glargine.
Bradley C; Gilbride CJ
Diabetes Obes Metab; 2008 Jul; 10 Suppl 2():50-65. PubMed ID: 18577157
[TBL] [Abstract][Full Text] [Related]
13. The role of new basal insulin analogues in the initiation and optimisation of insulin therapy in type 2 diabetes.
Baxter MA
Acta Diabetol; 2008 Dec; 45(4):253-68. PubMed ID: 18766296
[TBL] [Abstract][Full Text] [Related]
14. Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study.
Wenying Y; Benroubi M; Borzi V; Gumprecht J; Kawamori R; Shaban J; Shah S; Shestakova M; Ligthelm R; Valensi P;
Curr Med Res Opin; 2009 Nov; 25(11):2643-54. PubMed ID: 19751116
[TBL] [Abstract][Full Text] [Related]
15. Pharmacotherapies for diabetes management: an update for the practicing clinician.
Meneghini L; Hirsch IB
Semin Thorac Cardiovasc Surg; 2006; 18(4):379-89. PubMed ID: 17395035
[TBL] [Abstract][Full Text] [Related]
16. [Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)].
Hauner H; Kohlmann T; Landgraf W; Holle R; Pirk O; Scholten T
Dtsch Med Wochenschr; 2009 Jun; 134(23):1207-13. PubMed ID: 19472091
[TBL] [Abstract][Full Text] [Related]
17. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
Bode BW
Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
[TBL] [Abstract][Full Text] [Related]
18. Incretin-based therapies: review of the outpatient literature with implications for use in the hospital and after discharge.
Bode B; Amin A
Hosp Pract (1995); 2009 Dec; 37(1):7-21. PubMed ID: 20720383
[TBL] [Abstract][Full Text] [Related]
19. Fine-tuning therapy with basal insulin for optimal glycemic control in type 2 diabetes: a review.
Dailey G
Curr Med Res Opin; 2004 Dec; 20(12):2007-14. PubMed ID: 15701217
[TBL] [Abstract][Full Text] [Related]
20. Intensifying treatment of type 2 diabetes mellitus: adding insulin.
Peters KR
Pharmacotherapy; 2011 Dec; 31(12 Suppl):54S-64S. PubMed ID: 22122223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]